4//SEC Filing
Ban Kevin M. 4
Accession 0001618921-22-000098
CIK 0001618921other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 8:20 PM ET
Size
8.8 KB
Accession
0001618921-22-000098
Insider Transaction Report
Form 4
Ban Kevin M.
EVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-11-18−10,303→ 5,167 totalExercise: $34.04Exp: 2030-11-01→ Common Stock (10,303 underlying) - Exercise/Conversion
Common Stock
2022-11-18$34.04/sh+10,303$350,714→ 38,219 total - Sale
Common Stock
2022-11-18$40.19/sh−10,303$414,108→ 27,916 total
Footnotes (3)
- [F1]Includes shares underlying restricted stock units issued in lieu of dividends (through November 15, 2022) on outstanding restricted stock units.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.19 to $40.22, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated.
- [F3]The option, representing a right to purchase a total of 15,470 shares, became exercisable with respect to 5,151 shares on November 1, 2021, and with respect to 5,152 shares on November 1, 2022.
Documents
Issuer
Walgreens Boots Alliance, Inc.
CIK 0001618921
Entity typeother
Related Parties
1- filerCIK 0001947552
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 8:20 PM ET
- Size
- 8.8 KB